Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 63,611 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 97,970 | N/A | N/A | N/A | N/A |
| Accounts receivable | 16,996 | 971,616 | 478,479 | 2,162,520 | 1,613,723 |
| Accounts payable and accrued liabilities | 17,869 | -898,757 | -453,986 | -1,806,526 | -1,352,654 |
| Other Working Capital | -19,641 | 66,179 | 26,467 | 306,262 | 219,207 |
| Other Operating Activity | -26,547 | -71,059 | -21,514 | -388,944 | -247,180 |
| Operating Cash Flow | $150,258 | $67,979 | $29,446 | $273,312 | $233,096 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,746 | 7,294 | 1,287 | -9,631 | -1,450 |
| PPE Investments | -83,972 | -59,240 | -27,076 | -120,774 | -80,484 |
| Net Acquisitions | -3,490 | N/A | -895 | -44,627 | -43,645 |
| Purchase Of Investment | N/A | -2,589 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,375 | -1,321 | -1,307 | -15,479 | -15,488 |
| Other Investing Activity | -1,375 | -1,321 | -1,307 | -15,479 | -15,488 |
| Investing Cash Flow | $-83,091 | $-55,856 | $-27,991 | $-190,511 | $-141,067 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 74 | N/A | N/A | -253 | N/A |
| Debt Repayment | -206 | -131 | -66 | N/A | -181 |
| Common Stock Issued | 4,726 | 4,586 | 1,506 | 15,051 | 8,365 |
| Other Financing Activity | 259 | -1,725 | -1,771 | -3,109 | -120 |
| Financing Cash Flow | $4,853 | $2,730 | $-331 | $11,689 | $8,064 |
| Exchange Rate Effect | 22,058 | 22,029 | 11,353 | -12,790 | -7,051 |
| Beginning Cash Position | 413,251 | 413,251 | 413,251 | 331,551 | 331,551 |
| End Cash Position | 507,329 | 450,133 | 425,728 | 413,251 | 424,593 |
| Net Cash Flow | $94,078 | $36,882 | $12,477 | $81,700 | $93,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | 150,258 | 67,979 | 29,446 | 273,312 | 233,096 |
| Capital Expenditure | -84,013 | -59,269 | -27,080 | -120,999 | -80,865 |
| Free Cash Flow | 66,245 | 8,710 | 2,366 | 152,313 | 152,231 |